Wed, October 11, 2023

Prakhar Agrawal Maintained (AKRO) at Buy with Decreased Target to $39 on, Oct 11th, 2023

Prakhar Agrawal of Cantor Fitzgerald, Maintained "Akero Therapeutics, Inc." (AKRO) at Buy with Decreased Target from $69 to $39 on, Oct 11th, 2023.

Prakhar has made no other calls on AKRO in the last 4 months.



There are 2 other peers that have a rating on AKRO. Out of the 2 peers that are also analyzing AKRO, 0 agree with Prakhar's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Prakhar


  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $60 on, Wednesday, September 13th, 2023
  • Eliana Merle of "UBS" Initiated at Strong Buy and Held Target at $83 on, Monday, August 28th, 2023